Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
BVS
#2570
Bioventus Inc. Class A Common Stock
10.2
5
USD
+3.43%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+3.43%
Changement Mensuel
+17.41%
Evolution sur 6 mois
+48.12%
Changement Annuel
+33.29%
Clôture Précédente
9.9
1
Open
10.1
9
Bid
Ask
Low
10.1
8
High
10.2
5
Volume
16
Marchés
Actions des Marchés US
Soins de Santé
BVS
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
66.16 M
66.36 M
66.89 M
66.98 M
67.37 M
—
Valuation ratios
Enterprise value
1.19 B
1.11 B
896.58 M
870.35 M
906.63 M
3.79 B
Price to earnings ratio
-20.19
-20.8
165.5
41.37
22.55
208.62
Price to sales ratio
1.18
1.05
0.78
0.79
0.9
3.51
Price to cash flow ratio
17.47
22.8
12.19
8.05
6.87
49.91
Price to book ratio
4.58
1
0.72
0.71
2.78
5.22
Enterprise value to EBITDA ratio
29.79
26.37
9.82
9.39
2.19
47.77
Profitability ratios
Return on assets %
0
-0
0.01
0
0.02
0.03
Return on equity %
0.01
-0.01
0.04
0.02
0.06
0.1
Return on invested capital %
6.51
3.53
12.21
7.36
19
42.1
Gross margin %
66.82
67.05
69.14
67.96
68.89
273.04
Operating margin %
7.11
3.93
12.44
8.12
12.34
36.83
EBITDA margin %
15.29
12.98
20.47
16.27
19.55
69.27
Net margin %
1.43
-2.13
5.05
2.28
9.34
14.54
Liquidity ratios
Quick ratio
0.87
0.89
0.96
1.14
1.19
4.18
Current ratio
1.31
1.43
1.48
1.74
1.7
6.35
Inventory turnover
0.56
0.44
0.48
0.46
0.55
1.93
Asset turnover
0.21
0.17
0.21
0.2
0.23
0.81
Solvency ratios
Debt to assets ratio
0.46
0.5
0.48
0.46
0.43
1.88
Debt to equity ratio
2.27
2.34
2.12
1.95
1.6
8.01
Long term debt to total assets ratio
0.42
0.45
0.42
0.44
0.41
1.72
Long term debt to total equity ratio
2.08
2.08
1.85
1.87
1.52
7.32
Per share metrics
Operating cash flow per share
0.3
-0.29
0.38
0.44
0.55
1.07
EBIT per share
0.17
0.06
0.27
0.16
0.28
0.77
EBITDA per share
0.36
0.24
0.44
0.33
0.45
1.46
Total debt per share
5.21
5.25
4.99
4.7
4.28
19.22
Cash per share
0.64
0.35
0.48
0.61
0.74
2.18
Net current asset value per share
4.27
3.78
4.02
4.08
3.96
15.83
Tangible book value per share
-4.09
-3.86
-3.4
-3.18
-2.78
-13.23
Working capital per share
1.01
1.13
1.31
1.73
1.63
5.8
Book value per share
2.29
2.24
2.35
2.41
2.67
9.68
Nouvelles
Are Investors Undervaluing Bioventus (BVS) Right Now?
L’action Bioventus affiche un rendement de 63% après le signal de Juste Valeur
Bioventus stock delivers 63% return after Fair Value signal
Craig-Hallum relève l’objectif de cours de Bioventus après des résultats supérieurs aux prévisions
Craig-Hallum raises Bioventus stock price target on guidance beat
Bioventus Inc. (BVS) Q4 2025 Earnings Call Transcript
Bioventus Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:BVS) 2026-03-05
L’action Bioventus bondit de 7,6% après des résultats trimestriels supérieurs aux attentes
Bioventus shares jump 7.6% on fourth-quarter earnings beat
Le BPA de Bioventus a dépassé les attentes de 0,04$, le CA a surpassé les prévisions
Bioventus earnings beat by $0.04, revenue topped estimates
Bioventus dépasse les prévisions du T4, guidance 2026 conforme